Phase Two Trials Of A Leukemia Drug With Dr Juho Jalkanen Followed By Breakfast Decisions

A rare form of leukemia has had a drug for treatment show success in phase two trials. Dr Jalkanen has spent a large part of his career leading up to this. Then what drives your breakfast choices?